-risk patients with paravalvular leak (PVL) and
clinically significant regurgitation with feasibility
Beylerli, Ozal,
Ju, Jiaming,
Beilerli, Aferin,
Gareev, Ilgiz,
Shumadalova, Alina,
Ilyasova, Tatiana,
Bai, Yunlong,
Yang, Baofeng (2023) with structural heart disease and is a significant cause of morbidity and mortality in
clinical settings. AF
of TAMs and their increasing number of biomarkers, indicating their predictive value for the
clinical. These results have been confirmed by
clinical studies. The purpose of this review was to systematize
Torokulova, Karlygach T.,
Biyalieva, Gulmira S.,
Akulich, Elena N.,
Mamytova, Elmira A.,
Mamytova, Aina J.,
Akhmadeeva, Leila R. (2024) , data source, outcome definition, sample size, and predictors. The most common demographic,
clinical and
Objective. To evaluate the
clinical efficacy of long-term spinal and sacral programmable
Beylerli, Ozal,
Tamrazov, Rasim,
Gareev, Ilgiz,
Ilyasova, Tatiana,
Shumadalova, Alina,
Bai, Yunlong,
Yang, Baofeng (2023) into
clinical practice, including standardization of isolation and quantification methods, validation
. Moreover, we address the challenges of translating these findings into
clinical applications, including
. Despite the progress achieved in the field of oncology, HCC remains a significant
clinical challenge